I agree and understand.But keep in mind, there is value in the...

I agree and understand.

But keep in mind, there is value in the underlying Intellectual Property and Patents.

It then becomes a matter of identifying the potential application of that IP and Patent.

I think the real opportunity for GTG at the moment is to get momentum with their Multi-test product and tap into government subsidised funding, as preventative medicine will save governments lots of money. So GTG management need to build better relationships and/or employ people with those established relationships.

Hopefully EasyDNA will also give them some more global visibility and opportunity for increased sales.